Candida auris (C. auris) C. auris is an emerging fungus that can cause severe, often multidrug-resistant, infections. It spreads easily among patients in healthcare facilities.

Apr 24, 2024 · Candida auris (C. auris) is a type of yeast that can cause severe illness and spreads among patients in healthcare facilities. Symptoms of C. auris depend on the type of infection (i.e., bloodstream, wound, ears).

Apr 24, 2024 · Candida auris (C. auris) C. auris is an emerging fungus that can cause severe, often multidrug-resistant, infections. It spreads easily among patients in healthcare facilities.

Apr 24, 2024 · Candida auris (C. auris) is a fungus that can cause life-threatening, often multidrug-resistant, infections. C. auris affects ill or immunocompromised patients and is highly transmissible in healthcare settings.

Information about Candida auris including factsheets for general public, healthcare professionals, and laboratorians

Apr 24, 2024 · CDC does not recommend treatment for C. auris for any patient without signs or symptoms of infection. This includes both patients with C. auris colonization and patients with C. auris detected in noninvasive sites (i.e., respiratory tract or urine).

Apr 24, 2024 · C. auris can cause severe illness and spreads easily in healthcare facilities. Some patients carry C. auris on their skin or other body sites without it causing symptoms (colonization). Both infected and colonized patients can spread C. auris. Healthcare providers use many strategies to help stop C. auris from spreading.

Dec 9, 2024 · Clinical cases are patients with C. auris identified in a sample tested to find out the cause of an infection. The sample can be taken from either an invasive body site, such as blood or spinal fluid, or a non-invasive body site, like urine or wounds.

Apr 24, 2024 · Screening patients for C. auris is an important way to prevent or stop outbreaks in healthcare facilities and keep patients safe. Screening identifies patients with C. auris so that special precautions can be taken to prevent spread.

May 19, 2023 · Using a large US hospital database, we describe 192 Candida auris‒associated hospitalizations during 2017–2022, including 38 (20%) C. auris bloodstream infections. Hospitalizations involved extensive concurrent conditions and healthcare use; estimated crude mortality rate was 34%.